Memphis Daily News Chandler Reports Nashville Ledger
» Subscribe Today!
The Power of Information
Home
The Ledger - EST. 1978 - Nashville Edition
X
Skip Navigation LinksHome > Article
VOL. 42 | NO. 35 | Friday, August 31, 2018

BlueCross of Tennessee will stop covering OxyContin in 2019

Print | Front Page | Email this story

NAHSVILLE (AP) — Tennessee's largest health insurer will stop covering OxyContin prescriptions as part of an effort to combat opioid addiction.

BlueCross BlueShield of Tennessee's Natalie Tate tells The Tennessean the company will encourage doctors to recommend two alternatives to OxyContin, which BlueCross will cease paying for Jan. 1.

The suggested alternatives, Xtampza and Morphabond, are more expensive opioid pain relievers designed to be more difficult to abuse. Tate says customers will pay the same copay as for OxyContin, as BlueCross will absorb the additional cost.

OxyContin is manufactured by Purdue Pharma, which has been accused of intentionally fueling the opioid epidemic.

Medicare customers and approved cancer and hospice patients are exempt from the changes. Employee groups with self-funded insurance can opt out, and those insured by out-of-state BlueCross chapters will be unaffected.

Follow us on Facebook, Twitter & RSS:
Sign-Up For Our FREE email edition
Get the news first with our free weekly email
Name
Email  
TNLedger.com Knoxville Editon
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 0 0 0
MORTGAGES 0 0 0
FORECLOSURE NOTICES 0 0 0
BUILDING PERMITS 0 0 0
BANKRUPTCIES 0 0 0
BUSINESS LICENSES 0 0 0
UTILITY CONNECTIONS 0 0 0
MARRIAGE LICENSES 0 0 0